FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer

DOI: 10.1186/s12957-018-1359-9

Keywords: FOLFIRI, Panitumumab, Colorectal cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Patient characteristic

Full-Text